Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases

Chenhui Ma, Li Han, Zheying Zhu, Cheng Heng Pang and Guoyu Pan

Biochemical Pharmacology, 2022, 205, 115242
DOI: 10.1016/j.bcp.2022.115242

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC

Ioana Rusu, Radu Pirlog, Paul Chiroi, Andreea Nutu, Vlad Radu Puia, Alin Cornel Fetti, Daniel Radu Rusu, Ioana Berindan-Neagoe and Nadim Al Hajjar

IJMS, 2022, 23, 12370
DOI: 10.3390/ijms232012370

Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets

Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi and Stéphane Mandard

PPAR Research, 2022, 2022, 1
DOI: 10.1155/2022/6161694

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention

Rebeca Ortega, Bo Liu and Shanta J. Persaud

IJMS, 2023, 24, 10777
DOI: 10.3390/ijms241310777

The role of non-coding RNAs in ferroptosis regulation

Ran Qi, Yixuan Bai, Yuhua Wei, Nanbin Liu and Baomin Shi

Journal of Trace Elements in Medicine and Biology, 2022, 70, 126911
DOI: 10.1016/j.jtemb.2021.126911

Potential Effects of Nicotinamide on Serum HDL-Cholesterol Levels and Hepatic Oxidative Stress, ABCA1 Gene and Protein Expression in Rats Fed a High-Fat/Fructose Diet

Jesús I. Serafín-Fabián, Armando Ramírez-Cruz, J. D. Villeda-González, Jaime Gómez-Zamudio, Adrián Hernández-Díazcouder, Clara Ortega-Camarillo, Eugenia Flores-Alfaro, Miguel Cruz and Miguel Vazquez-Moreno

Nutrients, 2025, 17, 3458
DOI: 10.3390/nu17213458

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases

Hongmei You, Ling Wang, Fangtian Bu, Hongwu Meng, Cheng Huang, Guoying Fang and Jun Li

Cells, 2022, 11, 3301
DOI: 10.3390/cells11203301

ChREBP-β/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells

Hang Guo, Ting Fang, Ying Cheng, Ting Li, Jing-Ru Qu, Chao-fei Xu, Xiao-qing Deng, Bei Sun and Li-Ming Chen

Free Radical Biology and Medicine, 2023, 199, 154
DOI: 10.1016/j.freeradbiomed.2023.02.013

Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment

Chuwei Yu, Jing Chen and Jin Ren

Mol Biol Rep, 2022, 49, 9841
DOI: 10.1007/s11033-022-07503-0

Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease

Mohamed Zaiou

WJG, 2022, 28, 5111
DOI: 10.3748/wjg.v28.i35.5111

A class of MicroRNAs as diagnostic biomarkers and therapeutic strategies in non-alcoholic fatty liver disease: A review

Faraz Mahdizadeh, Pouria Sobhi and Shokofeh Banaei

Clinics and Research in Hepatology and Gastroenterology, 2025, 49, 102547
DOI: 10.1016/j.clinre.2025.102547

Al-MPS Obstructs EMT in Breast Cancer by Inhibiting Lipid Metabolism via miR-215-5p/SREBP1

Chenlu L Wu, Lili L Xu, Jing Peng and Danhua H Zhang

Endocrinology, 2022, 163
DOI: 10.1210/endocr/bqac040

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

Da Som Lee, Tae Hyeon An, Hyunmi Kim, Eunsun Jung, Gyeonghun Kim, Seung Yeon Oh, Jun Seok Kim, Hye Jin Chun, Jaeeun Jung, Eun-Woo Lee, Baek-Soo Han, Dai Hoon Han, Yong-Ho Lee, Tae-Su Han, Keun Hur, Chul-Ho Lee, Dae-Soo Kim, Won Kon Kim, Jun Won Park, Seung-Hoi Koo, Je Kyung Seong, Sang Chul Lee, Hail Kim, Kwang-Hee Bae and Kyoung-Jin Oh

Diabetologia, 2023, 66, 931
DOI: 10.1007/s00125-023-05878-8

Micro RNAs as Emerging Therapeutic Targets in Liver Diseases

Uzma Latief, Gurleen Kaur Tung, Tasir Sharief Per, Manjot Kaur, Shubham Thakur, Harjeet Singh and Subheet Kumar Jain

CPPS, 2022, 23, 369
DOI: 10.2174/1389203723666220721122240

Fructose and the Liver

Pablo Muriel, Pedro López-Sánchez and Erika Ramos-Tovar

IJMS, 2021, 22, 6969
DOI: 10.3390/ijms22136969

Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression

Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri and Sneha S. Pillai

Biomedicines, 2023, 11, 1597
DOI: 10.3390/biomedicines11061597

Update on genetics and epigenetics in metabolic associated fatty liver disease

Xiaopeng Zhu, Mingfeng Xia and Xin Gao

Therapeutic Advances in Endocrinology, 2022, 13
DOI: 10.1177/20420188221132138

Targeting GPX4-mediated Ferroptosis Alleviates Liver Steatosis in a Rat Model of Total Parenteral Nutrition

Siyang Cheng, Ying Wang, Yuling Zhao, Nan Wang, Junkai Yan, Lu Jiang and Wei Cai

Journal of Pediatric Surgery, 2024, 59, 981
DOI: 10.1016/j.jpedsurg.2023.10.048

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies

Han Zhang, Enxiang Zhang and Hongbo Hu

Biomedicines, 2021, 9, 1660
DOI: 10.3390/biomedicines9111660

Application of Proteomics in the Study of Toxicology and Toxic Markers of Traditional Chinese Medicines

Yang Yadi, Shang Ziyi, Hu Bin, Sun Ye, Li Jingjing, Ma Yujin, Jiang Hongwei, Liu Chuanxin and Li Xuejiao

Biomedical Chromatography, 2025, 39
DOI: 10.1002/bmc.70216

Micronutrients/miRs/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden

Siva Prasad Panda and Adarsh Kesharwani

Mitochondrion, 2023, 71, 1
DOI: 10.1016/j.mito.2023.05.003

SSBP1 drives high fructose-induced glomerular podocyte ferroptosis via activating DNA-PK/p53 pathway

Wen-Yuan Wu, Zi-Xuan Wang, Tu-Shuai Li, Xiao-Qin Ding, Zhi-Hong Liu, Jie Yang, Lei Fang and Ling-Dong Kong

Redox Biology, 2022, 52, 102303
DOI: 10.1016/j.redox.2022.102303

Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2

Bo Li, Ziyi Yang, Fei Mao, Wei Gong, Qing Su, Jialin Yang, Bin Liu, Yuping Song, Jie Jin and Yan Lu

Journal of Hepatology, 2023, 79, 1096
DOI: 10.1016/j.jhep.2023.06.019

MiRNA Regulates Ferroptosis in Cardiovascular and Cerebrovascular Diseases

Yiman Liu, Peijuan Yang, Jingjing Wang, Wu Peng, Jinli Zhao and Zuo Wang

DNA and Cell Biology, 2024, 43, 492
DOI: 10.1089/dna.2024.0135

Floralozone attenuates atherosclerotic vascular injury by regulating AMPKα/SREBP-1c pathway and down-regulating miR-33-5p

Ya-qi Guo, Hong-lin Zhao, Jin-ming Zhao, Shan-shan Li, Liu-wei Meng, Jiao Li, Yi-wen Qian, Yin-lan Li, Bao-yue Cui, Shuang Guo, Peng Li and Chang-zheng Li

Eur J Nutr, 2025, 64
DOI: 10.1007/s00394-024-03578-6

miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future

Roxana Liana Lucaciu, Olga Hilda Orasan, Adriana Corina Hangan, Mihaela Iancu, Angela Cozma, Sorina Cezara Coste, Sidonia Gog-Bogdan, Bogdan Sevastre and Lucia Maria Procopciuc

IJMS, 2025, 26, 10402
DOI: 10.3390/ijms262110402

SIRT3–IDH2 axis is a target of dietary fructose: implication of IDH2 as a key player in dietary carcinogen toxicity in mice colon

Jeong Hoon Pan, Nukhet Aykin-Burns, Kimberly J. Krager, Hyo Ri Shin, Chae Hwan Lee, Jin Hyup Lee, Byungwhi Kong, JaeEun Myoung, Kyung-Chul Choi and Jae Kyeom Kim

Exp Mol Med, 2025, 57, 2643
DOI: 10.1038/s12276-025-01584-0